• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多肽-MHC 结合的能量景观。

Energy landscapes of peptide-MHC binding.

机构信息

Institute for Biological Physics, University of Cologne, Cologne, Germany.

Tisch Cancer Institute, Departments of Oncological Sciences and Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.

出版信息

PLoS Comput Biol. 2024 Sep 3;20(9):e1012380. doi: 10.1371/journal.pcbi.1012380. eCollection 2024 Sep.

DOI:10.1371/journal.pcbi.1012380
PMID:39226310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11398667/
Abstract

Molecules of the Major Histocompatibility Complex (MHC) present short protein fragments on the cell surface, an important step in T cell immune recognition. MHC-I molecules process peptides from intracellular proteins; MHC-II molecules act in antigen-presenting cells and present peptides derived from extracellular proteins. Here we show that the sequence-dependent energy landscapes of MHC-peptide binding encode class-specific nonlinearities (epistasis). MHC-I has a smooth landscape with global epistasis; the binding energy is a simple deformation of an underlying linear trait. This form of epistasis enhances the discrimination between strong-binding peptides. In contrast, MHC-II has a rugged landscape with idiosyncratic epistasis: binding depends on detailed amino acid combinations at multiple positions of the peptide sequence. The form of epistasis affects the learning of energy landscapes from training data. For MHC-I, a low-complexity problem, we derive a simple matrix model of binding energies that outperforms current models trained by machine learning. For MHC-II, higher complexity prevents learning by simple regression methods. Epistasis also affects the energy and fitness effects of mutations in antigen-derived peptides (epitopes). In MHC-I, large-effect mutations occur predominantly in anchor positions of strong-binding epitopes. In MHC-II, large effects depend on the background epitope sequence but are broadly distributed over the epitope, generating a bigger target for escape mutations due to loss of presentation. Together, our analysis shows how an energy landscape of protein-protein binding constrains the target of escape mutations from T cell immunity, linking the complexity of the molecular interactions to the dynamics of adaptive immune response.

摘要

主要组织相容性复合体 (MHC) 的分子在细胞表面呈现短的蛋白质片段,这是 T 细胞免疫识别的重要步骤。MHC-I 分子处理来自细胞内蛋白质的肽;MHC-II 分子在抗原呈递细胞中起作用,并呈现来自细胞外蛋白质的肽。在这里,我们表明 MHC-肽结合的序列依赖性能量景观编码了类特异性的非线性(上位性)。MHC-I 具有平滑的景观和全局上位性;结合能是对基础线性特征的简单变形。这种上位性形式增强了对强结合肽的区分。相比之下,MHC-II 具有崎岖的景观和独特的上位性:结合取决于肽序列中多个位置的详细氨基酸组合。上位性的形式影响从训练数据中学习能量景观的方式。对于 MHC-I,这是一个低复杂度的问题,我们推导出一种简单的结合能矩阵模型,其性能优于通过机器学习训练的当前模型。对于 MHC-II,更高的复杂性阻止了简单回归方法的学习。上位性还影响抗原衍生肽(表位)中的突变的能量和适应性效应。在 MHC-I 中,大效应突变主要发生在强结合表位的锚定位置。在 MHC-II 中,大效应取决于背景表位序列,但广泛分布在表位中,由于呈递丢失而产生更大的逃逸突变目标。总的来说,我们的分析表明蛋白质-蛋白质结合的能量景观如何限制 T 细胞免疫逃逸突变的靶标,将分子相互作用的复杂性与适应性免疫反应的动力学联系起来。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c9f/11398667/633e41974d0a/pcbi.1012380.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c9f/11398667/7517e9d3be5a/pcbi.1012380.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c9f/11398667/268215fce6af/pcbi.1012380.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c9f/11398667/910d3a3c93d4/pcbi.1012380.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c9f/11398667/c8d4dc1022f7/pcbi.1012380.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c9f/11398667/633e41974d0a/pcbi.1012380.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c9f/11398667/7517e9d3be5a/pcbi.1012380.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c9f/11398667/268215fce6af/pcbi.1012380.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c9f/11398667/910d3a3c93d4/pcbi.1012380.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c9f/11398667/c8d4dc1022f7/pcbi.1012380.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c9f/11398667/633e41974d0a/pcbi.1012380.g005.jpg

相似文献

1
Energy landscapes of peptide-MHC binding.多肽-MHC 结合的能量景观。
PLoS Comput Biol. 2024 Sep 3;20(9):e1012380. doi: 10.1371/journal.pcbi.1012380. eCollection 2024 Sep.
2
Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.系统地对肽-MHC 结合预测因子进行基准测试:从合成到天然加工的表位。
PLoS Comput Biol. 2018 Nov 8;14(11):e1006457. doi: 10.1371/journal.pcbi.1006457. eCollection 2018 Nov.
3
Presentation of antigenic peptides by products of the major histocompatibility complex.主要组织相容性复合体产物对抗原肽的呈递
J Pept Sci. 1998 May;4(3):182-94. doi: 10.1002/(SICI)1099-1387(199805)4:3%3C182::AID-PSC144%3E3.0.CO;2-S.
4
Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides.自身主要组织相容性复合体肽的免疫原性和耐受性
J Exp Med. 1990 Nov 1;172(5):1341-6. doi: 10.1084/jem.172.5.1341.
5
Static energy analysis of MHC class I and class II peptide-binding affinity.主要组织相容性复合体I类和II类肽结合亲和力的静电能分析
Methods Mol Biol. 2007;409:309-20. doi: 10.1007/978-1-60327-118-9_23.
6
Distribution of tripeptides in MHC binding peptides.三肽在主要组织相容性复合体结合肽中的分布
Protein Pept Lett. 2007;14(6):552-6. doi: 10.2174/092986607780989895.
7
Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.迈向I类和II类小鼠主要组织相容性复合体-肽结合亲和力的预测:使用定量构效关系的计算机生物信息学逐步指南
Methods Mol Biol. 2007;409:227-45. doi: 10.1007/978-1-60327-118-9_16.
8
Peptides bound to major histocompatibility complex molecules.与主要组织相容性复合体分子结合的肽。
Peptides. 1998;19(1):179-98. doi: 10.1016/s0196-9781(97)00277-5.
9
Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules.与I类和II类主要组织相容性复合体分子结合的天然加工肽的结构分析。
EXS. 1995;73:105-19. doi: 10.1007/978-3-0348-9061-8_6.
10
Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.T细胞受体对MHC II类结合肽的核心和侧翼氨基酸的识别。
Eur J Immunol. 2002 Sep;32(9):2510-20. doi: 10.1002/1521-4141(200209)32:9<2510::AID-IMMU2510>3.0.CO;2-Q.

本文引用的文献

1
Epistasis and evolution: recent advances and an outlook for prediction.上位性与进化:最新进展与预测展望。
BMC Biol. 2023 May 24;21(1):120. doi: 10.1186/s12915-023-01585-3.
2
Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopes.机器学习预测 MHC-II 特异性揭示了 II 类抗原表位的另一种结合模式。
Immunity. 2023 Jun 13;56(6):1359-1375.e13. doi: 10.1016/j.immuni.2023.03.009. Epub 2023 Apr 5.
3
The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolution.SARS-CoV-2 奥密克戎 BA.1 进化过程中抗体结合亲和力的全景。
Elife. 2023 Feb 21;12:e83442. doi: 10.7554/eLife.83442.
4
Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1.补偿性上位性维持 SARS-CoV-2 奥密克戎 BA.1 中 ACE2 的亲和力。
Nat Commun. 2022 Nov 16;13(1):7011. doi: 10.1038/s41467-022-34506-z.
5
Cancer vaccines: the next immunotherapy frontier.癌症疫苗:下一个免疫治疗前沿。
Nat Cancer. 2022 Aug;3(8):911-926. doi: 10.1038/s43018-022-00418-6. Epub 2022 Aug 23.
6
Idiosyncratic epistasis leads to global fitness-correlated trends.特异地异位导致全局适应度相关趋势。
Science. 2022 May 6;376(6593):630-635. doi: 10.1126/science.abm4774. Epub 2022 May 5.
7
Global epistasis emerges from a generic model of a complex trait.全局上位性源自复杂性状的一般模型。
Elife. 2021 Mar 29;10:e64740. doi: 10.7554/eLife.64740.
8
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines.基于个性化新抗原的治疗性癌症疫苗的开发进展。
Nat Rev Clin Oncol. 2021 Apr;18(4):215-229. doi: 10.1038/s41571-020-00460-2. Epub 2021 Jan 20.
9
Idiosyncratic epistasis creates universals in mutational effects and evolutionary trajectories.特异地遗传交互作用导致了突变效应和进化轨迹的普遍性。
Nat Ecol Evol. 2020 Dec;4(12):1685-1693. doi: 10.1038/s41559-020-01286-y. Epub 2020 Sep 7.
10
Repertoire-scale determination of class II MHC peptide binding via yeast display improves antigen prediction.通过酵母展示进行 II 类 MHC 肽结合的库规模测定可改善抗原预测。
Nat Commun. 2020 Sep 4;11(1):4414. doi: 10.1038/s41467-020-18204-2.